- Login
- Register
- Home/Current Issue
- About the journal
- Editorial board
- Online submission
- Instructions for authors
- Subscriptions
- Foundation Acta Endocrinologica
- Archive
- Contact
Romanian Academy
The Publishing House of the Romanian Academy
ACTA ENDOCRINOLOGICA (BUC)
The International Journal of Romanian Society of Endocrinology / Registered in 1938in Web of Science Master Journal List
Acta Endocrinologica(Bucharest) is live in PubMed Central
Journal Impact Factor - click here.
This Article
Services
Google Scholar
PubMed
Acta Endocrinologica (Buc)
Dong Q, Liu X, Wang F, Xu Y, Liang C, Du W, Gao G
Dynamic Changes of TRAb and TPOAb after Radioiodine Therapy in Graves’ Disease
Acta Endo (Buc) 2017, 13 (1): 72-76doi: 10.4183/aeb.2017.72
Context. To analyze the dynamic changes of serum
thyrotrophin receptor antibody (TRAb) and thyroid peroxidase
antibody (TPOAb) in Graves’ disease (GD) patients before
and after radioactive iodine (RAI) treatment and to investigate
if TRAb and TPOAb play a role in the occurrence of early
hypothyroidism after 131I therapy for Graves’ hyperthyroidism.
Subjects and Methods. A total of 240 patients newly
diagnosed with GD were selected to study. A clinical and
laboratory assessment was performed before and at 3, 6, and
12 months after 131I therapy. Chemiluminescent immunoassays
were used to detect serum free triiodothyronine (FT3), free
thyroxine (FT4), sensitive thyroid-stimulating hormone (TSH)
and TPOAb concentration. Radio-receptor assay was used to
measure serum TRAb concentration. According to the early
onset of hypothyroidism in a year after RAI therapy, patients
were divided into early hypothyroidism group (group A) and
non-early hypothyroidism group (group B).
Results. In both groups, serum TRAb and TPOAb
increased at 3 months, reached the highest level at 6 months
and returned to the baseline at 12 months after RAI therapy.
TRAb showed a significant difference between the two groups
at 6 months (P<0.01). Serum TPOAb in group A was higher
than that in group B before and at 3, 6, 12 months after RAI
therapy (P<0.05).
Conclusions. Serum TRAb and TPOAb are closely
related to the occurrence of the early hypothyroidism, and play
an important role in judging prognosis after 131I treatment in
Graves’ disease.
Keywords: Graves’ disease, radioiodine therapy, hypothyroidism, thyrotrophin receptor antibody (TRAb), thyroid peroxidase antibody (TPOAb)
Correspondence: Guanqi Gao, Department of Endocrinology, People’s Hospital of Linyi City, No. 27, Jie Fang Road, Linyi, Shandong, 276003, China, E-mail: gaoguanqi16@163.com